WeTrials
Recruiting

A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)

What is this study?

This study is testing a new medication called nemtabrutinib to see if it works better than standard treatments for adults with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. These are slow-growing blood cancers that affect white blood cells and lymph nodes.

Who can participate?

You might be able to join if you have been diagnosed with active chronic lymphocytic leukemia or small lymphocytic lymphoma that needs treatment for the first time. Participants must also be well enough to carry out daily activities and able to swallow pills easily.

What will happen?

Participants will be randomly assigned to receive either the new study medication, nemtabrutinib, or one of two currently available standard treatments. Your health team will closely monitor you throughout the study to see how well the treatment is working and check for any side effects.

Where and when?

This study is currently recruiting participants at select locations in places like Mobile, Alabama, and Gilbert and Phoenix, Arizona. Your study doctor can give you more details about the exact location closest to you.

Key Points
  • 1Testing a new cancer pill called nemtabrutinib against standard treatments
  • 2For adults with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma
  • 3Study is currently active and looking for participants

Related videos

2

VJHemOnc: Dr. Tamar Tadmor introduces the BELLWAVE-011 trial (June 2024)

OSUCCC – James: Dr. Jennifer Woyach on how nemtabrutinib, the study drug, works (June 2024)

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.